What is DuraGraft®?
DuraGraft is the first and only approved solution for the preservation of vascular conduits to reduce complications of vein graft disease and vein graft failure. An estimated 49% of patients going through CABG procedures experience at least one vein graft failure in the first year following surgery while an individual vein graft has a 30% chance of failure within the first year.
This single-use intraoperative vascular graft treatment improves clinical outcomes by preventing ischemic injury and subsequent reperfusion injury thereby maintaining endothelial function, thereby reducing the incidence and complications of graft failure.
DuraGraft is not yet available for sale in the United States.
